Cost-effectiveness of routine measuring of serum drug concentrations and anti-drug antibodies in treatment of rheumatoid arthritis patients with TNF-α blockers

Monitoring of anti-drug antibodies (ADAbs) or serum concentrations of biologicals in treatment of rheumatoid arthritis could provide an explanation for a loss of efficacy and help in the choice of subsequent medication. Current clinical practices do not generally include such monitoring of tumor nec...

Descripción completa

Detalles Bibliográficos
Autores principales: Laine, Juha, Jokiranta, T Sakari, Eklund, Kari K, Väkeväinen, Merja, Puolakka, Kari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824281/
https://www.ncbi.nlm.nih.gov/pubmed/27099470
http://dx.doi.org/10.2147/BTT.S96982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824281/
https://www.ncbi.nlm.nih.gov/pubmed/27099470
http://dx.doi.org/10.2147/BTT.S96982

Ejemplares similares